SS&C Technologies (SSNC) to Release Earnings on Thursday

SS&C Technologies (NASDAQ:SSNC) is anticipated to release its Q1 2025 earnings data after the market closes on Thursday, April 24th. Analysts expect SS&C Technologies to post earnings of $1.40 per share and revenue of $1.50 billion for the quarter. SS&C Technologies has set its FY 2025 guidance at 5.640-5.960 EPS and its Q1 2025 guidance at 1.370-1.430 EPS.

SS&C Technologies (NASDAQ:SSNC) last posted its quarterly earnings results on Thursday, February 6th. The technology company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.32 by $0.09. SS&C Technologies had a return on equity of 18.30% and a net margin of 12.93%. On average, analysts expect SS&C Technologies to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

SS&C Technologies Trading Down 3.6 %

Shares of SSNC opened at $73.55 on Tuesday. SS&C Technologies has a 1 year low of $60.01 and a 1 year high of $89.73. The company has a 50 day simple moving average of $82.31 and a two-hundred day simple moving average of $78.56. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.21 and a quick ratio of 1.21. The firm has a market cap of $18.12 billion, a P/E ratio of 24.52 and a beta of 1.31.

SS&C Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were issued a $0.25 dividend. The ex-dividend date was Monday, March 3rd. This represents a $1.00 dividend on an annualized basis and a yield of 1.36%. SS&C Technologies’s dividend payout ratio is currently 33.33%.

Insider Buying and Selling at SS&C Technologies

In other SS&C Technologies news, SVP Jason Douglas White sold 71,000 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $88.96, for a total value of $6,316,160.00. Following the transaction, the senior vice president now directly owns 6,412 shares in the company, valued at $570,411.52. This represents a 91.72 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael Jay Zamkow sold 23,000 shares of SS&C Technologies stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $88.39, for a total transaction of $2,032,970.00. Following the sale, the director now directly owns 23,200 shares of the company’s stock, valued at $2,050,648. This represents a 49.78 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 16.40% of the company’s stock.

Analysts Set New Price Targets

SSNC has been the subject of a number of research analyst reports. UBS Group raised their price objective on SS&C Technologies from $92.00 to $93.00 and gave the company a “buy” rating in a research report on Monday, February 3rd. Royal Bank of Canada upped their price objective on SS&C Technologies from $86.00 to $96.00 and gave the stock an “outperform” rating in a report on Friday, February 7th. StockNews.com raised shares of SS&C Technologies from a “buy” rating to a “strong-buy” rating in a research note on Monday, February 10th. Raymond James lifted their price objective on shares of SS&C Technologies from $85.00 to $95.00 and gave the stock a “strong-buy” rating in a research note on Friday, February 7th. Finally, Needham & Company LLC upped their target price on shares of SS&C Technologies from $90.00 to $105.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Five investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $97.17.

About SS&C Technologies

SS&C Technologies Holdings, Inc engages in the development and provision of software solutions to the financial services and healthcare industries. It operates through the following geographical segments: United States, Europe, Middle East and Africa, Asia Pacific and Japan, Canada, and the Americas, excluding the United States and Canada.